Clinical Trials Logo

Clinical Trial Summary

This study aims to investigate the treatment of intrauterine adhesion and the factors influencing its prognosis.


Clinical Trial Description

Intrauterine adhesion, also known as Asherman's syndrome, is the partial or complete occlusion of the uterine cavity as a result of endometrium damage. Most intrauterine adhesions patients manifest amenorrhea, reduced menstrual pattern, infertility, and intrauterine growth restriction, which seriously affect their reproductive health.It is well established that the formation of intrauterine adhesion likely involves hypoxia, reduced neovascularization, and altered expression of adhesion associated cytokines, but the exact mechanisms are not well understood. Although excessive curettage is considered the primary cause, intrauterine adhesion is known to be associated with diverse non-traumatic factors, such as postabortal sepsis, puerperal sepsis and infections. Intrauterine adhesion separation surgery is the gold standard for the treatment of uterine adhesion. Although the success rate is as high as 95%, the patients with moderate or severe uterine adhesion have severe damage to the endometrial basement, poor regeneration of endometrial and gland, poor tolerance of endometrial and poor clinical prognosis. Even if all kinds of anti-adhesion measures are used comprehensively, the postoperative recurrence rate of patients with moderate and severe uterine adhesion is high.Therefore this study was conducted to investigate whether intrauterine lavage or intrauterine gel-injection therapy after surgery could reduce the recurrence of intrauterine adhesion, promote the endometrial growth and repair and improve the menstruation and reproductive prognosis for severe intrauterine adhesion, and we hypothesize that intrauterine adhesion may be related to changes in microbial flora in the reproductive tract. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03731689
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Yaling Guo, master
Phone 15622327162
Email 1106561876@qq.com
Status Recruiting
Phase N/A
Start date May 1, 2018
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT02313415 - Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells N/A
Not yet recruiting NCT02132104 - Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery N/A
Completed NCT02744807 - Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions N/A
Terminated NCT01632202 - Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy Phase 4
Not yet recruiting NCT02404454 - Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel N/A
Recruiting NCT02496052 - The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions N/A
Recruiting NCT02204358 - Treatment of Infertility by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells Phase 4